Luoyang · Henan · GMP Certified

Sulfonamide & Quinolone APIs, Made Clean

Luoyang Zhengmu Bio-Tech is a GMP-certified manufacturer of veterinary APIs: sulfonamides, quinolones and their key intermediates. Thirteen products, 1,000 tonnes a year, released against Chinese Veterinary Pharmacopoeia, BP, EP and USP specifications.
1,000 tAnnual Capacity
13APIs & Intermediates
300,000Grade Cleanroom
4Pharmacopoeia Standards
Veterinary Drug GMP Chinese Veterinary Pharmacopoeia BP · EP · USP 300,000-Grade Clean Workshop Yanshi · Henan · China
Who We Are

A single-focus veterinary API plant in Yanshi, Henan

Luoyang Zhengmu Bio-Tech Co., Ltd. operates from Liuzhuang Village, Goushi Town, Yanshi City, Henan Province. We are a professional veterinary drug manufacturer and hold GMP certification for veterinary medicines.
Our sulfa range covers Sulfadimidine, Sulfadimidine Sodium, Sulfadiazine, Sulfadiazine Sodium, Sulfaguanidine, Sulfamethoxazole Sodium, Diaveridine and Diaveridine HCl. Our quinolone range covers Norfloxacin and its hydrochloride, lactate and nicotinate salts, plus Pefloxacin Mesylate.
More About Zhengmu
Sulfonamide Line
Eight sulfa APIs and intermediates, from Sulfadimidine to Diaveridine HCl.
Quinolone Line
Five fluoroquinolone APIs including three Norfloxacin salt forms.
1,000 t per Year
Multi-purpose synthesis lines for APIs and intermediates, glass and stainless steel.
300,000-Grade Cleanroom
Refining, drying and packing of APIs handled in a dedicated clean plant.
In-House QC
HPLC, GC, IR and UV spectrometry, titration and particle counting on site.
Four Standards
Batch release against ChP, BP, EP or USP, whichever your dossier requires.
Product Portfolio

Thirteen APIs across two therapeutic families

Every product below is manufactured in-house and released with a certificate of analysis. CAS numbers are listed so your regulatory team can match them to an existing dossier.

Sulfonamides

Antibacterial sulfa drugs and their sodium salts, used in poultry, swine and cattle health programmes.
SulfadimidineCAS 57-68-1
Sulfadimidine SodiumCAS 1981-58-4
SulfadiazineCAS 68-35-9
Sulfadiazine SodiumCAS 547-32-0
Sulfamethoxazole SodiumCAS 4563-84-2
SulfaguanidineCAS 57-67-0
DiaveridineCAS 5355-16-8
Diaveridine HClCAS 2507-23-5

Quinolones

Fluoroquinolone antibacterials supplied as base or as soluble salt forms for drinking-water formulations.
NorfloxacinCAS 70458-96-7
Norfloxacin HClCAS 104142-93-0
Norfloxacin LactateCAS 97867-34-0
Norfloxacin NicotinateCAS 118803-81-9
Pefloxacin MesylateCAS 70458-95-6
See Full Specifications
Quality & Compliance

GMP certification, then the testing that backs it

Certification is the entry ticket. What customers audit is whether every batch is tested and documented the same way, year after year.
  • Veterinary drug GMP certificate for API manufacture
  • Batch release against ChP, BP, EP or USP specifications
  • Certificate of analysis issued with every shipment
  • HPLC assay, related substances and residual solvent testing
  • Full batch traceability from raw material to packed drum
  • Customer audits and specification reviews welcomed

  • Analysis instruments on site

    1. High performance liquid chromatography (HPLC)
    2. Gas chromatography (GC)
    3. Infrared and ultraviolet spectrophotometers
    4. Automatic titrator and moisture analyser
    5. Melting point and pH analysers, particle counter

    Plant & Capacity

    • Multi-purpose synthesis lines for APIs and intermediates
    • Glass and stainless steel equipment, GMP-installed
    • 300,000-grade clean plant for refining, drying and packing
    • 1,000 tonnes of finished product per year
    • Plant designed by a pharmaceutical engineering consultancy
    Where We Ship

    Veterinary APIs supplied to formulators worldwide

    Products are sold to customers in China and exported to formulators, distributors and registration holders in established and emerging animal-health markets.
    ChinaSoutheast AsiaSouth AsiaMiddle East Latin AmericaAfricaEuropeCIS

    Need a sulfa or quinolone API quotation?

    Send your specification, target pharmacopoeia and annual volume. Our export team replies with price, lead time and documentation package.
    Request a Quote
    © 2026 Luoyang Zhengmu Bio-Tech Co., Ltd. All rights reserved. Liuzhuang Village, Goushi Town, Yanshi, Henan, China · +86-379-67490366
    Skip to main content

    Posts

    Sustainable Biomanufacturing Starts in Process Development

    Sustainable biomanufacturing must begin in process development, not after commercial production starts. Most environmental impact is locked in during technology selection, process design and supply chain planning, long before the first batch runs. By the time a plant operates, the biggest choices are already made. Sustainability should not start after manufacturing starts; it should start while the process is still being designed. Why the factory's energy bill is not the whole story When biopharma companies talk about green manufacturing, the usual list runs: energy saving, water saving, solar power, packaging optimization, waste management and green logistics. These measures all matter. But for biological drugs, a better question is how much room remains to change resource consumption after a process has been commercialized. For sustainable biomanufacturing, the honest answer is usually: not much. This is green bioprocessing by design. Many environmental impacts are not created du...